Effects of plant-based diet on metabolic parameters, liver and kidney steatosis: a prospective interventional open-label study

被引:1
作者
Senturk, Begum Guler [1 ]
Gurses, Bengi [2 ]
Soyturk, Ceren [3 ]
Copur, Sidar [1 ]
Incir, Said [4 ]
Siriopol, Dimitrie [5 ]
Hasbal, Nuri Baris [6 ]
Akyildiz, Murat [7 ]
van Raalte, Daniel H. [8 ]
Kanbay, Mehmet [6 ]
机构
[1] Koc Univ, Dept Internal Med, Sch Med, Istanbul, Turkiye
[2] Koc Univ, Dept Radiol, Sch Med, Istanbul, Turkiye
[3] Koc Univ Hosp, Istanbul, Turkiye
[4] Koc Univ, Dept Clin Biochem, Sch Med, Istanbul, Turkiye
[5] St John New Cty Hosp, Dept Nephrol, Suceava, Romania
[6] Koc Univ, Dept Internal Med, Div Nephrol, Sch Med, Istanbul, Turkiye
[7] Koc Univ, Dept Internal Med, Div Gastroenterol, Sch Med, Istanbul, Turkiye
[8] Univ Amsterdam, Diabet Ctr, Dept Internal Med, Med Ctr, Amsterdam, Netherlands
关键词
Vegetarian diet; Non-alcoholic fatty liver disease; Chronic kidney disease; Steatosis; Hepatosteatosis; DISEASE; EPIDEMIOLOGY; PREVALENCE;
D O I
10.1017/S0007114525000017
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This interventional single-centre prospective open-label study aims to evaluate the effects of a vegan diet, compared with a vegetarian and omnivorous diet, on metabolic parameters, insulin sensitivity, and liver and kidney steatosis in healthy adults. The study included fifty-three omnivorous participants aged 18-40 years, BMI 18-30 kg/m2, without any chronic disease, chronic medication use, active smoking or significant alcohol consumption. All participants were omnivorous at baseline and selected to continue an omnivorous diet or transition to a vegetarian or vegan diet, with follow-up over 6 months. Anthropometric measurements, biochemical parameters and liver and kidney steatosis were assessed at baseline and after six months using MRI-proton density fat fraction. Primary outcomes included changes in liver and kidney steatosis, while secondary outcomes were alterations in anthropometric and biochemical markers. Among fifty-three participants, eighteen followed an omnivorous diet, twenty-one adopted a vegetarian diet and fourteen transitioned to a vegan diet. Dietary interventions did not result in statistically significant changes in BMI, fat mass, fat percentage or muscle mass over 6 months. However, statistically significant improvements in systolic and diastolic blood pressure, favouring the vegan diet, were observed. We aimed to control for potentially confounding variables to ensure the reliability of these findings. We have demonstrated a better decline in steatosis at the lower kidney pole, the total hilus and the Liver 6 index in vegans. We demonstrated that a plant-based diet is associated with improvements in several metabolic parameters and may reduce liver and kidney steatosis.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 50 条
  • [41] Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study
    Van Mil, Dominique
    Kieneker, Lyanne M.
    Evers-Roeten, Birgitte
    Thelen, Marc H. M.
    de Vries, Hanne
    Hemmelder, Marc H.
    Dorgelo, Annemiek
    Van Etten, Ronald W.
    Heerspink, Hiddo J. L.
    Gansevoort, Ron
    LANCET, 2023, 402 (10407) : 1052 - 1064
  • [42] The effect of nebivolol and ramipril on selected biochemical parameters, arterial stiffness, and circadian profile of blood pressure in young men with primary hypertension: A 12-week prospective randomized, open-label study trial
    Walczak-Galezewska, Marta
    Szulinska, Monika
    Miller-Kasprzak, Ewa
    Pupek-Musialik, Danuta
    Bogdanski, Pawel
    MEDICINE, 2018, 97 (30)
  • [43] Effects of a Lacto-Ovo-Vegetarian Diet on the Plasma Lipidome and Its Association with Atherosclerotic Burden in Patients with Coronary Artery Disease-A Randomized, Open-Label, Cross-over Study
    Djekic, Demir
    Shi, Lin
    Calais, Fredrik
    Carlsson, Frida
    Landberg, Rikard
    Hyotylainen, Tuulia
    Frobert, Ole
    NUTRIENTS, 2020, 12 (11) : 1 - 16
  • [44] Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trial
    Brenner, Thorsten
    Skarabis, Annabell
    Stevens, Philip
    Axnick, Jennifer
    Haug, Peter
    Grumaz, Silke
    Bruckner, Thomas
    Luntz, Steffen
    Witzke, Oliver
    Pletz, Mathias W.
    Ruprecht, Thomas M.
    Marschall, Ursula
    Altin, Sibel
    Greiner, Wolfgang
    Berger, Marc Moritz
    TRIALS, 2021, 22 (01)
  • [45] An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
    Yang, Pei-Shan
    Chen, Chien-Lun
    Hou, Chen-Pang
    Lin, Yu-Hsiang
    Tsui, Ke-Hung
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 235 - 242
  • [46] Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study
    Kinoshita, Tomoe
    Shimoda, Masashi
    Nakashima, Koji
    Fushimi, Yoshiro
    Hirata, Yurie
    Tanabe, Akihito
    Tatsumi, Fuminori
    Hirukawa, Hidenori
    Sanada, Junpei
    Kohara, Kenji
    Irie, Shintaro
    Kimura, Tomohiko
    Nakamura, Yoshiko
    Nishioka, Momoyo
    Obata, Atsushi
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1612 - 1622
  • [47] Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
    Hugh Gallagher
    Jennifer Dumbleton
    Tom Maishman
    Amy Whitehead
    Michael V. Moore
    Ahmet Fuat
    David Fitzmaurice
    Robert A. Henderson
    Joanne Lord
    Kathryn E. Griffith
    Paul Stevens
    Maarten W. Taal
    Diane Stevenson
    Simon D. Fraser
    Mark Lown
    Christopher J. Hawkey
    Paul J. Roderick
    Trials, 23
  • [48] Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
    Gallagher, Hugh
    Dumbleton, Jennifer
    Maishman, Tom
    Whitehead, Amy
    Moore, Michael, V
    Fuat, Ahmet
    Fitzmaurice, David
    Henderson, Robert A.
    Lord, Joanne
    Griffith, Kathryn E.
    Stevens, Paul
    Taal, Maarten W.
    Stevenson, Diane
    Fraser, Simon D.
    Lown, Mark
    Hawkey, Christopher J.
    Roderick, Paul J.
    TRIALS, 2022, 23 (01)
  • [49] Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients
    Smets, Francoise
    Dobbelaere, Dries
    McKiernan, Patrick
    Dionisi-Vici, Carlo
    Broue, Pierre
    Jacquemin, Emmanuel
    Lopes, Ana Isabel
    Goncalves, Isabel
    Mandel, Hanna
    Pawlowska, Joanna
    Kaminska, Diana
    Shteyer, Eyal
    Torre, Giuliano
    Shapiro, Riki
    Eyskens, Francois
    Clapuyt, Philippe
    Gissen, Paul
    Pariente, Daniele
    Grunewald, Stephanie
    Yudkoff, Marc
    Binda, Maria Mercedes
    Najimi, Mustapha
    Belmonte, Nathalie
    de Vos, Beatrice
    Thonnard, Joelle
    Sokal, Etienne
    TRANSPLANTATION, 2019, 103 (09) : 1903 - 1915
  • [50] Electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): A single-arm, open-label, single-assignment trial
    Torimoto, Kazumasa
    Gotoh, Daisuke
    Nakai, Yasushi
    Miyake, Makito
    Fujimoto, Kiyohide
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (07) : 1559 - 1565